BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 3431872)

  • 1. [Clinical course and transformation of polycythemia vera and its relation to applied therapy].
    Burger T; Schmelczer M; Molnár L; Pajor L; Koszorús S
    Orv Hetil; 1987 Dec; 128(52):2723-30. PubMed ID: 3431872
    [No Abstract]   [Full Text] [Related]  

  • 2. Polycythemia: a disease of all ages.
    Libre EP
    Geriatrics; 1974 Oct; 29(10):124-34. PubMed ID: 4415114
    [No Abstract]   [Full Text] [Related]  

  • 3. Patho-anatomical features of the bone marrow.
    Lennert K; Nagai K; Schwarze EW
    Clin Haematol; 1975 Jun; 4(2):331-51. PubMed ID: 1102191
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies.
    Ellis JT; Peterson P; Geller SA; Rappaport H
    Semin Hematol; 1986 Apr; 23(2):144-55. PubMed ID: 3704666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
    Berk PD; Goldberg JD; Donovan PB; Fruchtman SM; Berlin NI; Wasserman LR
    Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association of polycythemia vera and multiple myeloma. Presentation ofa new case and review of the literature].
    Prósper F; Paloma MJ; Rifón J; Cuesta B; Hermida J; Rocha E
    Sangre (Barc); 1993 Dec; 38(6):497-9. PubMed ID: 8171387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polycythemia vera. Clinical course, diagnosis and therapy].
    Braumann D; Mainzer K
    Dtsch Med Wochenschr; 1983 Oct; 108(40):1524-9. PubMed ID: 6617509
    [No Abstract]   [Full Text] [Related]  

  • 8. Natural history and management of polycythemia vera.
    Hoffman R; Wasserman LR
    Adv Intern Med; 1979; 24():255-85. PubMed ID: 371361
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurologic complications of polycythemia and their impact on therapy.
    Newton LK
    Oncology (Williston Park); 1990 Mar; 4(3):59-64; discussion 64-6. PubMed ID: 2144446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelosuppression in polycythemia vera: chemotherapy or radiotherapy?
    Najean Y; Dresch C
    Blut; 1982 Jan; 44(1):1-5. PubMed ID: 7059686
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacious treatment of a fatal blood disease: polycythemia vera].
    Sánchez Fayos J; Román Barbero A; Nevado Reviriego I
    Sangre (Barc); 1997 Jun; 42(3):215-8. PubMed ID: 9381264
    [No Abstract]   [Full Text] [Related]  

  • 12. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
    Nand S; Stock W; Godwin J; Fisher SG
    Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential thrombocythemia following polycythemia vera: an unusual sequence.
    Randi ML; Barbone E; Zerbinati P; Soini B; Rossi C; Girolami A
    J Med; 1996; 27(5-6):363-8. PubMed ID: 9151204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment by radiophosphorus versus busulfan in polycythemia vera: a randomized trial (E.O.R.T.C.'s) "leukemias and hematosarcomas" group.
    Recent Results Cancer Res; 1977; (62):104-9. PubMed ID: 341245
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.
    Berk PD; Goldberg JD; Silverstein MN; Weinfeld A; Donovan PB; Ellis JT; Landaw SA; Laszlo J; Najean Y; Pisciotta AV; Wasserman LR
    N Engl J Med; 1981 Feb; 304(8):441-7. PubMed ID: 7005681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The treatment of myeloproliferative syndromes].
    Maurice P
    Schweiz Med Wochenschr; 1975 Oct; 105(40):1269-74. PubMed ID: 1061995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of patients with polycythemia vera on busulfan or 32P.
    Mathé G
    N Engl J Med; 1978 Feb; 298(5):279. PubMed ID: 619270
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute leukemia in polycythemia vera.
    Landaw SA
    Semin Hematol; 1986 Apr; 23(2):156-65. PubMed ID: 3704667
    [No Abstract]   [Full Text] [Related]  

  • 19. Pipobroman (Vercyte) - a new antineoplastic drug.
    Med Lett Drugs Ther; 1967 Apr; 9(7):27. PubMed ID: 5298493
    [No Abstract]   [Full Text] [Related]  

  • 20. [Essential thrombocythemia: conventional therapy].
    Grossi A; Vannucchi AM; Longo G; Rafanelli D; Rossi Ferrini P
    Haematologica; 1991 Jun; 76 Suppl 3():368-70. PubMed ID: 1752534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.